Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you're unlikely to be protected if something goes wrong. Take 2 mins to see our risk warning.
Access market-leading, predictable income from a defensive sector.
Our Pharmacy Income opportunity offers structured financing backed by NHS trade receivables.
Invest in our 3-year Wakala Note with an expected 10% annual profit, paid through periodic distributions.
This opportunity is designed to provide a secure, predictable income stream, complementing venture capital or private equity portfolios.
10% annually
£5,000
36 months
The Cur8 Pharmacy Income opportunity allows UK tax payers to invest up to £20,000 per year tax-free.
If you’re in the higher UK tax bracket, investing through our IF-ISA means your tax-free return is equivalent to a 16.7% returnoutside an ISA.
Distributions are paid in line with the agreed schedule, giving investors structured, predictable returns.
Invested in the Pharmacy Income Fund
Active investors
Funding new pharmacy acquisitions, increasing availability of NHS-backed healthcare services across more locations.
Investing in automation, inventory optimisation, and cost-saving efficiencies to improve service delivery.
Implementing digital healthcare solutions, enabling high-margin services such as consultations, NHS-funded care, and private healthcare offerings.
Supporting the consolidation of independent pharmacies into a service-led, tech-enabled healthcare group, enhancing financial resilience and future value.